1-2 of 2
Christen N. Heye, ARNP
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) Is Active and Well-Tolerated in Adults with Newly-Diagnosed Acute Lymphoblastic Leukemia/Lymphoma (ALL): Initial Results of a Phase II Trial

Ryan D. Cassaday, MD, Lorinda A. Soma, MD, Olga Sala-Torra, MD, Philip A. Stevenson, MS, Mary-Elizabeth M. Percival, MD, Vivian G. Oehler, MD, Andrei R. Shustov, MD, Pamela S. Becker, MD, Anna B. Halpern, MD, Kelsey-Leigh Garcia, Christen N. Heye, ARNP, Jerald P. Radich, MD, Elihu H. Estey, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1419.
https://doi.org/10.1182/blood-2018-99-110661
Published: 2018
Journal Articles

Radiographic and High-Throughput Sequencing (HTS)-Based Response Assessment after Brentuximab Vedotin (BV) Plus Ifosfamide, Carboplatin, and Etoposide (ICE) for Relapsed/Refractory (Rel/Ref) Classical Hodgkin Lymphoma (cHL): Updated Results of a Phase I/II Trial

Ryan D. Cassaday, MD, Jonathan R. Fromm, MD PhD, Andrew J. Cowan, MD, Stephen D. Smith, MD, Edward N. Libby, III, MD, Mary Philip, MD PhD, Margaret E. Nartea, Christen N. Heye, ARNP, Sandra L. Kanan, ARNP, Sanaz Behnia, MD, Ajay K. Gopal, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2806.
https://doi.org/10.1182/blood.V130.Suppl_1.2806.2806
Published: 2017